Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Cincinnati Financial Corporation (CINF) Price & Performance

BridgeBio Pharma IncTrade
Cincinnati Financial CorporationTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Cincinnati Financial Corporation — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.58B). The key difference: Cincinnati Financial Corporation is the larger of the two by market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

BBIOCINF
Market Cap
$16.36B$26.58B
Sector
HealthFinancials
52-Week High
$90.17$192.03
52-Week Low
$47.29$149.79
Enterprise Value
$18.14B$25.71B
Dividend Yield
2.17%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF